EcoDrugPlus

Ensembl ID : ENSCCRG00000038381
Gene Symbol: TIE1
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSCCRG00000026732
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSCCRG00000025659
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Ensembl ID : ENSCCRG00000025329
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSCCRG00000025260
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSCCRG00000025195
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSCCRG00000025153
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSCCRG00000044563
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSCCRG00000023815
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSCCRG00000055659
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSCCRG00000022667
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSCCRG00000055843
Gene Symbol: -
Cross references: -
169 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).